U.S. Sen. Debbie Stabenow (D-Mich.) will not seek re-election in 2024, a decision that will deprive 340B covered entities of a reliable ally in Congress.
Stabenow issued a statement yesterday announcing her decision. She was one of six senators—three…
The 340B statute was written as a drug pricing program that outlines specifically what manufacturers are required to charge qualified covered entities for their drugs based on a defined formula. The intent of the 340B program is to help these safety net entities stretch their scarce resources to maintain and…
340B INDUSTRY LEADER SPOTLIGHT
William von Oehsen, Principal, Powers Law Firm
Q: Where did you grow up?
Central New Jersey
Q: Where did you go to college/graduate school?
Princeton (AB), Harvard (MTS), Georgetown (JD)
Q: What are your favorites?…